Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 1 21Phase 1/2 16Phase 3 9Phase EARLY_PHASE1 2Phase NA 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 1041Neoplasms 872Prostatic Neoplasms 506Lung Neoplasms 421Colorectal Neoplasms 357Motor Activity 219Head and Neck Neoplasms 194Uterine Cervical Neoplasms 189Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 114Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, T-Cell, Peripheral × 1 year × Clear all
NCT07072221 2025-07-18

Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients

The First Affiliated Hospital of Soochow University

Phase NA Recruiting
40 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡